0001171843-20-002465.txt : 20200407
0001171843-20-002465.hdr.sgml : 20200407
20200407174906
ACCESSION NUMBER: 0001171843-20-002465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200403
FILED AS OF DATE: 20200407
DATE AS OF CHANGE: 20200407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wei Binxian
CENTRAL INDEX KEY: 0001773586
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33672
FILM NUMBER: 20780601
MAIL ADDRESS:
STREET 1: P.O. BOX 2231
CITY: LIVINGSTON
STATE: NJ
ZIP: 07039
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seneca Biopharma, Inc.
CENTRAL INDEX KEY: 0001357459
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 522007292
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20271 GOLDENROD LANE
STREET 2: STE 2024
CITY: GERMANTOWN
STATE: MD
ZIP: 20876
BUSINESS PHONE: 301-366-4841
MAIL ADDRESS:
STREET 1: 20271 GOLDENROD LANE
STREET 2: STE 2024
CITY: GERMANTOWN
STATE: MD
ZIP: 20876
FORMER COMPANY:
FORMER CONFORMED NAME: Neuralstem, Inc.
DATE OF NAME CHANGE: 20060324
4
1
ownership.xml
X0306
4
2020-04-03
0
0001357459
Seneca Biopharma, Inc.
SNCA
0001773586
Wei Binxian
20271 GOLDENROD LANE, 2ND FLOOR
GERMANTOWN
MD
20876
1
0
0
0
Restricted Stock Units
2020-04-03
4
A
0
6000
0.00
A
Common Stock
6000
6000
D
Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
N/A
/s/ Binxian Wei
2020-04-07